ESPRITTA Trademark

Trademark Overview


On Monday, February 3, 2014, a trademark application was filed for ESPRITTA with the United States Patent and Trademark Office. The USPTO has given the ESPRITTA trademark a serial number of 86182945. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2015. This trademark is owned by Glaxo Group Limited. The ESPRITTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
espritta

General Information


Serial Number86182945
Word MarkESPRITTA
Filing DateMonday, February 3, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 17, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ESPRITTA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 13, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, March 16, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 12, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 17, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 17, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 28, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 8, 2014ASSIGNED TO EXAMINER
Thursday, February 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 6, 2014NEW APPLICATION ENTERED IN TRAM